Avisi Technologies, Inc
Developing a nanotechnology-enabled glaucoma device
Philadelphia, United States · Founded 2019 · $10.7M raised
- Headquarters
- Philadelphia, Pennsylvania
- Employees
- 1–10
- Founded
- 2019
- Business Model
- B2B
- Website
- avisitech.com
- Total Funding
- $10.7M
- Last Round
- $10.7M Series AFeb 2026
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Avisi Technologies is a medical device company developing VisiPlate, a nanotechnology-enabled ocular implant for treating glaucoma. Founded in 2017 through the University of Pennsylvania Y-Prize program, Avisi applies materials science and ophthalmology to create accessible, cutting-edge healthcare solutions. The VisiPlate device creates a new outflow pathway for aqueous humor and is currently under clinical investigation.
Summary
Avisi Technologies, Inc is a Biotech company based in Philadelphia, United States, founded in 2019. It has raised $10.7M in total across 1 round, most recently a $10.7M Series A round in Feb 2026. Investors include MedVenture and Sherpa Healthcare Partners.
Funding History
Feb 2026
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Integrated biopharmaceutical solutions company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/avisi-technologies-inc"><img src="https://indexed.vc/api/badge/company/avisi-technologies-inc" alt="Avisi Technologies, Inc on Indexed.vc" width="260" height="76" /></a>